1-7 of 7
George J Joseph, BPharm, MS, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Connor Willis, PharmD, Jyothi Menon, PhD, Sudhir Unni, PhD, Trang Au, PharmD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4745.
https://doi.org/10.1182/blood-2018-99-115009
Published: 2018
Journal Articles

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Minkyoung Yoo, Jyothi Menon, PhD, Connor Willis, PharmD, Sudhir Unni, PhD, Trang Au, PharmD, Joseph Biskupiak, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J. Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5857.
https://doi.org/10.1182/blood-2018-99-113479
Published: 2018
Journal Articles

Cost-Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States

Eytan M. Stein, MD, Jipan Xie, MD PhD, Emilie Duchesneau, Subrata Bhattacharyya, PhD, Briana Ndife, MPH, Gaetano Bonifacio, MD, George J Joseph, BPharm, MS, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4703.
https://doi.org/10.1182/blood.V130.Suppl_1.4703.4703
Published: 2017
Journal Articles

Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States

Karen Seiter, MD, Dominick Latremouille-Viau, Annie Guerin, MS, Briana Ndife, MPH, Karen Habucky, PhD, George J Joseph, BPharm, MS, PhD, Irina Pivneva, PhD, Patrick Gagnon-Sanschagrin, MS, Derek H Tang, BSPharm, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3391.
https://doi.org/10.1182/blood.V130.Suppl_1.3391.3391
Published: 2017
Journal Articles

Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation

Ellen K Ritchie, MD, Dominick Latremouille-Viau, Annie Guerin, MS, Irina Pivneva, PhD, Karen Habucky, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Ehab Atallah, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3396.
https://doi.org/10.1182/blood.V130.Suppl_1.3396.3396
Published: 2017
Journal Articles

Reduction in Healthcare Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia (CML) with Better Adherence to Tyrosine Kinase Inhibitors (TKIs) and Increased Molecular Monitoring Frequency

Dominick Latremouille-Viau, MSc, Annie Guerin, MSc, Patrick Gagnon-Sanschagrin, BSc, Katherine Dea, MSc, Benjamin Cohen, MPH, George J Joseph, BPharm, MS, PhD
Journal: Blood
Blood (2016) 128 (22): 2398.
https://doi.org/10.1182/blood.V128.22.2398.2398
Published: 2016
Journal Articles

Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Eytan M. Stein, MD, Dominick Latremouille-Viau, MSc, Annie Guerin, MSc, Sherry Shi, MSc, Patrick Gagnon-Sanschagrin, BSc, Gaetano Bonifacio, MD, George J Joseph, BPharm, MS, PhD
Journal: Blood
Blood (2016) 128 (22): 5929.
https://doi.org/10.1182/blood.V128.22.5929.5929
Published: 2016